Globus Medical (GMED) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Globus Medical Reports Fourth Quarter and Full Year 2021 Results
February 17, 2022 4:20 PM ESTAUDUBON, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2021.
Fourth Quarter 2021:
Worldwide net sales were $250.0 million, an increase of 7.1% as compared to the fourth quarter of 2020GAAP net income for the quarter was $15.1 millionGAAP diluted earnings per share (EPS) was $0.14 and non-GAAP diluted EPS was $0.49Non-GAAP adjusted EBITDA was $85.2 million, or 34.1% of net... More